keyword
https://read.qxmd.com/read/38562359/chemical-pleurodesis-in-the-treatment-of-recurrent-chylothorax-due-to-renal-cell-carcinoma
#1
Hannah Z Weiss, Brandon W Knopp, Jeniel Parmar
Chylothorax is defined as a pleural effusion with triglyceride levels greater than 110 mg/dL and/or chylomicrons present in the pleural fluid. A chylothorax may be classified as traumatic or nontraumatic, with malignancy being the most common cause of atraumatic chylothoraces. Herein, we present the case of a 63-year-old woman with a past medical history of a mediastinal teratoma and stage III colon adenocarcinoma who presented to the emergency room with new-onset shortness of breath. A week prior to presentation, she was diagnosed with metastatic renal cell carcinoma after a retrocrural lymph node was biopsied...
March 2024: Curēus
https://read.qxmd.com/read/38545351/a-case-of-lung-adenocarcinoma-developing-chylothorax-after-transthoracic-tru-cut-biopsy
#2
Şerife Torun, Çağrı Kesim, Mehmet Dalokay Kılıç
Chylothoraces are mostly secondary to trauma and tumors, and rarely idiopathic. Chylothoraces secondary to lung tumors are mostly seen postoperatively. In this article, we, for the first time, present massive chylothorax developing after diagnostic transthoracic Tru-cut biopsy in a lung adenocarcinoma case. The patient was successfully treated with drainage and octreotide. In conclusion, it should be kept in mind that chylothorax can be also seen as a complication after interventional biopsy procedures; therefore, the patients should be followed carefully...
January 2024: Türk Göğüs Kalp Damar Cerrahisi Dergisi
https://read.qxmd.com/read/38234347/management-of-a-decade-old-recurrent-chylothorax-with-breast-fistulization-a-case-report
#3
Trevor C Chopko, Saiesh R Voppuru, Emily C Bendel, Janani S Reisenauer
BACKGROUND: Chylothoraces result from traumatic or non-traumatic insult to the thoracic duct, allowing for lymph to accumulate in the chest. Patients present with increasing dyspnea and fatigue, and the diagnosis is made via chest X-ray, computed tomography (CT), and comparative analysis of the pleural fluid and serum. Management largely entails diet modification and drainage with or without adjunct medications, reserving pleurodesis, percutaneous duct embolization, or thoracic duct ligation for recalcitrant cases...
2024: AME Case Reports
https://read.qxmd.com/read/38234337/intraoperative-chylous-leak-diagnosis-by-preoperative-oral-administration-of-ice-cream-a-case-report
#4
Nobutaka Kawamoto, Riki Okita, Masanori Okada, Masataro Hayashi, Hidetoshi Inokawa
BACKGROUND: Chylothorax is an intractable postoperative complication of thoracic surgery. Preventing postoperative chylothorax following initial surgery is important. Most cases of chylothorax are caused by injury to the thoracic duct or its branches. However, rare cases might result from injury to the lymphatic vessels in the chest wall. Preoperative oral administration of dairy products is widely recognized as a useful method for identifying the sites of chylous leaks during surgery for chylothoraces...
2024: AME Case Reports
https://read.qxmd.com/read/37942032/fluorescence-guided-surgery-with-indocyanine-green-to-identify-an-idiopathic-chyle-leak-case-report
#5
Patrick Bou-Samra, Austin Chang, Sunil Singhal, Maxim Itkin
BACKGROUND: Chylothorax is the leakage of chyle into the pleural space and is associated with up to 50% morbidity. Although, the identification of traumatic chylothoraces is well described, non-traumatic chylothoraxes, mostly idiopathic, present therapeutic challenges as they are difficult to localize. We describe an attempt at localizing and treating an idiopathic chylothorax refractory to conservative and minimally invasive techniques. This was done using indocyanine green (ICG) and was a joint case between a thoracic surgeon and an interventional radiologist...
2023: AME Case Reports
https://read.qxmd.com/read/37850216/clinical-characteristics-of-chylothorax-results-from-the-international-collaborative-effusion-database
#6
JOURNAL ARTICLE
José M Porcel, Silvia Bielsa, Carmen Civit, Avinash Aujayeb, Julius Janssen, Uffe Bodtger, Katrine Fjaellegaard, Jesper Koefod Petersen, Hugh Welch, Jenny Symonds, Michael A Mitchell, Elżbieta Magdalena Grabczak, Mohamed Ellayeh, Dinesh Addala, John M Wrightson, Najib M Rahman, Mohammed Munavvar, Coenraad F N Koegelenberg, Gonzalo Labarca, Federico Mei, Nick Maskell, Rahul Bhatnagar
BACKGROUND: Chylothorax is an uncommon medical condition for which limited data are available regarding the contemporary aetiology, management and outcomes. The goal of this study was to better define these poorly characterised features. METHODS: The medical records of adult patients diagnosed with chylothorax at 12 centres across Europe, America and South Africa from 2009-2021 were retrospectively reviewed. Descriptive and inferential statistics were performed...
September 2023: ERJ Open Research
https://read.qxmd.com/read/37721463/nutrition-for-critically-ill-children-with-congenital-heart-disease
#7
REVIEW
Jason S Kerstein, Corie M Klepper, Emily G Finnan, Kimberly I Mills
Children with congenital heart disease often require admission to the cardiac intensive care unit at some point in their lives, either after elective surgical or catheter-based procedures or during times of acute critical illness. Meeting both the macronutrient and micronutrient needs of children in the cardiac intensive care unit requires complex decision-making when considering gastrointestinal perfusion, vasoactive support, and fluid balance goals. Although nutrition guidelines exist for critically ill children, these cannot always be extrapolated to children with congenital heart disease...
October 2023: Nutrition in Clinical Practice
https://read.qxmd.com/read/37455693/dasatinib-induced-chylothorax-beyond-5-years-of-treatment-is-there-actually-any-limit
#8
JOURNAL ARTICLE
Alberto Garcia-Zamalloa, Begoña Basauri, Goretti Urcelay, Adriana Sainz
UNLABELLED: Dasatinib is a tyrosine kinase inhibitor used for treatment of some specific types of leukaemia. The development of pleural effusion is a known adverse effect of dasatinib and chylothorax is exceptional. No case has been reported beyond 5 years of treatment and extensive search for an alternative diagnosis is currently suggested in such scenario. The underlying mechanism is not currently clear. We describe a woman on dasatinib treatment for more than 10 years who developed chylothorax...
2023: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/37221001/transudative-chylothorax-and-frailty-a-diagnostic-and-therapeutic-challenge
#9
JOURNAL ARTICLE
Liz Robinson, Sze Ooi, Ben Prudon
Transudative chylothoraces are a rare entity and their management in the presence of multiorgan dysfunction and frailty is complex. A woman in her 90s was investigated during acute hospital admission and found unexpectedly to have a transudative chylothorax secondary to cryptogenic cirrhosis. Not all chylothoraces have the classically described milky appearances and a high index of suspicion is vital in determining appropriate investigation and management. Our patient required repeated thoracocentesis and subsequently chose to be discharged from hospital with comfort care...
May 23, 2023: BMJ Case Reports
https://read.qxmd.com/read/37182072/chylous-ascites-developing-into-bilateral-chylothorax-in-high-grade-lymphoma-a-case-report
#10
Jonathan T Avon, Allison J Gerrard, Brijesh B Patel
Chylothorax and chylous ascites occur when lymphatic fluid accumulates in the pleural space or peritoneum, respectively. They are classified as either traumatic or non-traumatic, and lymphomas are the most common non-traumatic cause. Lymphomas can obstruct the lymphatic architecture causing lipid-rich chyle to leak out below the level of the obstructing mass. Bilateral chylothoraces presenting in the presence of chylous ascites, secondary to Non-Hodgkin Lymphoma, are rare. We describe a case of a 55-year-old man with recurring large-volume chylous ascites secondary to Non-Hodgkin lymphoma who developed bilateral chylothoraces...
April 2023: Curēus
https://read.qxmd.com/read/37159433/persistent-chylothorax-associated-with-lymphatic-malformation-type-6-due-to-biallelic-pathogenic-variants-in-piezo1
#11
Thomas Kovesi, Samantha K Rojas, Kym M Boycott
PIEZO1 is required for lymphatic valve formation, and several lymphatic abnormalities have been reported to be associated with autosomal recessive PIEZO1 pathogenic variants including neonatal hydrops, lymphedema involving various body regions, and chylothorax. Persistent or recurrent chylothorax has been infrequently described in association with pathogenic variants in the PIEZO1 gene. We present a 4-year-old female with bilateral pleural effusions detected prenatally, who was diagnosed with bilateral chylothoraces post-partum...
May 9, 2023: American Journal of Medical Genetics. Part A
https://read.qxmd.com/read/36819322/left-sided-transudative-chylothorax-with-concomitant-chylous-ascites-in-the-setting-of-liver-cirrhosis
#12
Janet Gukasyan, Alexander T Phan, Janie Hu, Shuhab Zaher, Sarkis Arabian, Mufadda Hasan, Dan Vo
Most chylothoraces are caused by trauma and malignancy, and pleural fluid analysis typically demonstrates an exudative effusion. Transudative chylothorax is a rare manifestation and has only been cited in case reports in the current literature. Here, we present the case of a 59-year-old male with a history of liver cirrhosis secondary to alcohol abuse, chronic kidney disease stage 3a, and hypertension who presented with a left-sided pleural effusion and abdominal ascites. A thoracentesis and abdominal paracentesis were performed, and fluid analyses demonstrated a transudative chylothorax with concomitant chylous ascites...
January 2023: Curēus
https://read.qxmd.com/read/36651059/propranolol-therapy-for-congenital-chylothorax
#13
JOURNAL ARTICLE
Roxane Handal-Orefice, Devin Midura, June K Wu, Elvira Parravicini, Russell S Miller, Carrie J Shawber
Congenital chylothorax is a rare and often severe anomaly without well-established medical therapies. Previously, propranolol use in patients with lymphatic malformations and secondary chylothorax was associated with improvement in clinical signs. We hypothesized that propranolol treatment would be beneficial for severe congenital chylothorax. We reviewed medical records of neonates born from 2015 to 2019 at our tertiary center with a prenatal diagnosis of congenital chylothorax for whom either prenatal or postnatal propranolol therapy was initiated...
February 1, 2023: Pediatrics
https://read.qxmd.com/read/36337134/non-traumatic-chylothorax-diagnostic-and-therapeutic-strategies
#14
REVIEW
Khalil Ur Rehman, Parthipan Sivakumar
UNLABELLED: Non-traumatic chylothorax refers to accumulation of chyle in the pleural space in the absence of any traumatic disruption to the thoracic duct. Chyle originates from the intestines and is transported via the thoracic duct into systemic circulation. The anatomical course of the thoracic duct is complex with considerable variation; therefore, development of chylothorax is dependent on the site and level of the thoracic duct defect. Non-traumatic chylothorax is associated with a wide range of medical disorders, but malignancy accounts for three-quarters of cases...
June 2022: Breathe
https://read.qxmd.com/read/36255468/octreotide-for-acquired-chylothorax-in-pediatric-patients-post-cardiothoracic-surgery-for-congenital-heart-disease-a-systematic-review
#15
REVIEW
A C Jenkinson, J McGuinness, T Prendiville
Chylothorax is a life-threatening complication post-corrective congenital heart surgery. Octreotide is used for treatment of refractory chylothoraces, with no standardized treatment protocol and a paucity of literature describing its efficacy. Our aim was to provide an update on the safety and efficacy of octreotide for the treatment of refractory chylothoraces in neonatal and pediatric patients' post-corrective congenital heart surgery. We performed a systematic review of PubMed, Medline, CINAHL, and Cochrane Library databases...
February 2023: Pediatric Cardiology
https://read.qxmd.com/read/36238151/case-report-progressive-central-conducting-lymphatic-abnormalities-in-the-rasopathies-two-case-reports-including-successful-treatment-by-mek-inhibition
#16
Kristiana Gordon, Matthew Moore, Malou Van Zanten, Julian Pearce, Maxim Itkin, Brendan Madden, Lakshmi Ratnam, Peter S Mortimer, Rani Nagaraja, Sahar Mansour
The RASopathies are a group of genetic conditions resulting from mutations within the RAS/mitogen-activated protein kinase (RAS-MAPK) pathway. Lymphatic abnormalities are commonly associated with these conditions, however central conducting lymphatic abnormalities (CCLA) have only recently been described. CCLAs may be progressive and can result in devastating systemic sequelae, such as recurrent chylothoraces, chylopericardium and chylous ascites which can cause significant morbidity and even mortality. Improvements in imaging modalities of the central lymphatics have enhanced our understanding of these complex abnormalities...
2022: Frontiers in Genetics
https://read.qxmd.com/read/36051238/transudative-chylothorax-in-a-liver-cirrhosis-patient-a-case-report
#17
Rose Nganga, Christian Pulliam, William Sessions, Amber Stola, Justin Gregg
Chylothorax defines chyle in the pleural space, usually from defects in thoracic duct. Chylothoraces are usually exudative, as defined by light's criteria but in rare instances, chylothoraces can be transudative. The leading cause of non-traumatic chylothorax is malignancy, but a non-traumatic chylothorax can be a rare manifestation of liver cirrhosis. In this case report, we present a case of an 82-year-old male with a history of non-alcoholic liver cirrhosis requiring multiple paracenteses for chylous ascites in the past, who was found to have a transudative non-traumatic chylothorax...
2022: Respiratory Medicine Case Reports
https://read.qxmd.com/read/35831752/intranodal-cone-beam-computed-tomographic-lymphangiography-with-water-soluble-iodinated-contrast-agent-for-evaluating-chylothorax-in-infants-preliminary-experience-at-a-single-institution
#18
JOURNAL ARTICLE
Dicken Wong, Kin Fen Kevin Fung, Hay-Son Robin Chen, Kin Sing Lun, Yee Ling Elaine Kan
This brief report demonstrates the diagnostic utility of cone-beam CT lymphangiography (CBCTL) with intranodal injection of water-soluble iodinated contrast agent for assessing lymphatic disorders in two infants who were contraindicated for MRI and oil-based contrast agent. Both infants had dextro-transposition of the great arteries (d-TGA) and presented with high-output chylothoraces that were recalcitrant to conservative medical therapy. Both infants were diagnosed with central lymphatic flow disorder based on the CBCTL findings...
July 14, 2022: Pediatric Radiology
https://read.qxmd.com/read/35788405/brief-report-chylothorax-and-chylous-ascites-during-ret-tyrosine-kinase-inhibitor-therapy
#19
MULTICENTER STUDY
Or Kalchiem-Dekel, Christina J Falcon, Christine M Bestvina, Dazhi Liu, Lauren A Kaplanis, Clare Wilhelm, Jordan Eichholz, Guilherme Harada, Lori J Wirth, Subba R Digumarthy, Robert P Lee, David Kadosh, Robin B Mendelsohn, Jessica Donington, Justin F Gainor, Alexander Drilon, Jessica J Lin
INTRODUCTION: Spontaneous chylous effusions are rare; however, they have been observed by independent investigators in patients treated with RET tyrosine kinase inhibitors (TKIs). METHODS: This multicenter, retrospective study evaluated the frequency of chylous effusions in patients treated with RET TKIs. Clinicopathologic features and management of patients with chylous effusions were evaluated. RESULTS: A pan-cancer cohort of 7517 patients treated with one or more multikinase inhibitor or selective RET TKI and a selective TKI cohort of 96 patients treated with selpercatinib or pralsetinib were analyzed...
September 2022: Journal of Thoracic Oncology
https://read.qxmd.com/read/35646098/a-novel-homozygous-missense-mutation-of-piezo1-leading-to-lymphatic-malformation-6-identified-in-a-family-with-three-adverse-pregnancy-outcomes-due-to-nonimmune-fetal-hydrops
#20
JOURNAL ARTICLE
Shuai Han, Xin Guo, Xiaogang Wang, Huijun Lin, Yiqi Yu, Jing Shu, Minyue Dong, Liwei Yang
Lymphatic malformation-6 (LMPHM6) is a rarer form of nonimmune hydrops that often manifests as widespread lymphedema involving all segments of the body, namely, subcutaneous edema, intestinal/pulmonary lymphangiectasia, chylothoraces, and pleural/pericardial effusions. Here, we detected one rare and previously unobserved homozygous missense variant in PIEZO1 (c.5162C>G, p.Ser1721Trp) as a novel genetic cause of autosomal recessive LMPHM6, in a family with three adverse pregnancy outcomes due to nonimmune fetal hydrops...
2022: Frontiers in Genetics
keyword
keyword
171451
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.